vs
Side-by-side financial comparison of INTELLIGENT PROTECTION MANAGEMENT CORP. (IPM) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
INTELLIGENT PROTECTION MANAGEMENT CORP. is the larger business by last-quarter revenue ($6.1M vs $3.9M, roughly 1.6× Opus Genetics, Inc.). On growth, INTELLIGENT PROTECTION MANAGEMENT CORP. posted the faster year-over-year revenue change (2091.6% vs -10.2%). Over the past eight quarters, INTELLIGENT PROTECTION MANAGEMENT CORP.'s revenue compounded faster (54.7% CAGR vs 50.3%).
Intelligent Limited is a Holding Company and Parent company headquartered in Gloucestershire, United Kingdom and was incorporated on 21 May 2008. Intelligent Limited provides a group management structure for four companies and was born out of the operations of International Intelligence Limited, a company specialising in Intelligence, Counter Espionage and TSCM sweeping.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
IPM vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $6.1M | $3.9M |
| Net Profit | — | — |
| Gross Margin | 53.1% | — |
| Operating Margin | -13.4% | — |
| Net Margin | — | — |
| Revenue YoY | 2091.6% | -10.2% |
| Net Profit YoY | — | 53.0% |
| EPS (diluted) | $-0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $6.1M | $3.9M | ||
| Q3 25 | $6.2M | $3.1M | ||
| Q2 25 | $5.7M | $2.9M | ||
| Q1 25 | $5.5M | $4.4M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $3.9M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | — | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-1.1M | $-17.5M | ||
| Q2 25 | $-1.1M | $-7.4M | ||
| Q1 25 | $808.5K | $-8.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-7.5M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | — | $-7.1M |
| Q4 25 | 53.1% | — | ||
| Q3 25 | 50.7% | — | ||
| Q2 25 | 50.1% | — | ||
| Q1 25 | 55.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -13.4% | — | ||
| Q3 25 | -23.0% | -269.9% | ||
| Q2 25 | -19.7% | -309.0% | ||
| Q1 25 | -24.2% | -227.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -207.1% | ||
| Q2 24 | — | -748.9% | ||
| Q1 24 | — | -450.5% |
| Q4 25 | — | — | ||
| Q3 25 | -17.4% | -566.9% | ||
| Q2 25 | -18.3% | -257.5% | ||
| Q1 25 | 14.7% | -187.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -194.6% | ||
| Q2 24 | — | -698.3% | ||
| Q1 24 | — | -415.3% |
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.08 | $-0.25 | ||
| Q2 25 | $-0.08 | $-0.12 | ||
| Q1 25 | $0.06 | $-0.24 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.29 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.6M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $18.2M | $15.3M |
| Total Assets | $26.0M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.6M | $45.1M | ||
| Q3 25 | $7.3M | $30.8M | ||
| Q2 25 | $7.3M | $32.4M | ||
| Q1 25 | $9.7M | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $41.4M | ||
| Q1 24 | — | $47.2M |
| Q4 25 | $18.2M | $15.3M | ||
| Q3 25 | $18.8M | $6.0M | ||
| Q2 25 | $19.9M | $17.5M | ||
| Q1 25 | $21.1M | $5.1M | ||
| Q4 24 | — | $6.7M | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | $40.6M | ||
| Q1 24 | — | $46.1M |
| Q4 25 | $26.0M | $50.2M | ||
| Q3 25 | $27.2M | $36.1M | ||
| Q2 25 | $29.8M | $38.7M | ||
| Q1 25 | $31.1M | $48.2M | ||
| Q4 24 | — | $36.9M | ||
| Q3 24 | — | $40.4M | ||
| Q2 24 | — | $44.8M | ||
| Q1 24 | — | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $87.6K | $-35.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $87.6K | $-35.3M | ||
| Q3 25 | $133.0K | $-6.2M | ||
| Q2 25 | $-888.7K | $-10.3M | ||
| Q1 25 | $1.7M | $-9.0M | ||
| Q4 24 | — | $-25.6M | ||
| Q3 24 | — | $-5.1M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | — | $-5.7M |
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 2.16× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IPM
| Procurement Revenue | $5.4M | 88% |
| Other | $743.9K | 12% |
IRD
Segment breakdown not available.
